|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Sec Filings Insider Trading - Aclaris Therapeutics Inc. (ACRS)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |
Historical filings delayed by 6 months. New user?
Sign Up for real time data.
Existing user?
Sign In
Common stock purchase or sale:
| Transaction Date |
Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2017-08-16 Purchase |
2017-08-16 4:45 pm |
Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director |
108,601 | $23.02 | $2,499,995 | 634,455 (Indirect) |
View |
| 2017-02-28 Sale |
2017-03-02 8:44 pm |
Aclaris Therapeutics Inc. | ACRS | VIVO VENTURES VII LLC Vivo Ventures Fund VII L.P. Vivo Ventures VII Affiliates Fund L.P. 10% Owner |
425,000 | $30.82 | $13,098,000 | 3,017,798 (Indirect) |
View |
| 2017-01-10 Sale |
2017-01-12 5:50 pm |
Aclaris Therapeutics Inc. | ACRS | Mehra Anand Director |
750,000 | $28.25 | $21,188,325 | 1,539,480 (Indirect) |
View |
| 2016-11-16 Sale |
2016-11-18 7:44 pm |
Aclaris Therapeutics Inc. | ACRS | VIVO VENTURES VII LLC Vivo Ventures Fund VII L.P. Vivo Ventures VII Affiliates Fund L.P. 10% Owner |
907,828 | $23.03 | $20,908,049 | 3,653,934 (Indirect) |
View |
| 2016-10-26 Sale |
2016-10-28 4:10 pm |
Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer |
3,912 | $21.83 | $85,399 | 79,869 (Direct) |
View |
| 2016-10-26 Sale |
2016-10-28 3:39 pm |
Aclaris Therapeutics Inc. | ACRS | FMR LLC Other 10% Owner |
3,750 | $21.94 | $82,260 | 2,571,454 (Indirect) |
View |
| 2016-09-26 Sale |
2016-09-28 6:10 pm |
Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer |
1,841 | $24.66 | $45,399 | 77,798 (Direct) |
View |
| 2016-09-15 Sale |
2016-09-19 5:15 pm |
Aclaris Therapeutics Inc. | ACRS | RA CAPITAL MANAGEMENT LLC Kolchinsky Peter RA Capital Healthcare Fund LP 10% Owner |
525,550 | $24.19 | $12,713,502 | 2,607,719 (Indirect) |
View |
| 2016-08-26 Sale |
2016-08-29 4:15 pm |
Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer |
3,738 | $20.35 | $76,068 | 20,289 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported Date |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2017-08-09 Option Award |
2017-08-14 08:21 am |
N/A 2027-08-08 |
Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director |
16,000 | $26.97 | 16,000 (Direct) |
View |
| 2017-06-15 Option Award |
2017-06-16 7:46 pm |
N/A 2027-06-14 |
Aclaris Therapeutics Inc. | ACRS | Bierly Rick Director |
8,000 | $24.58 | 8,000 (Direct) |
View |
| 2017-06-15 Option Award |
2017-06-16 7:46 pm |
N/A 2027-06-14 |
Aclaris Therapeutics Inc. | ACRS | Humphries William D. Director |
8,000 | $24.58 | 8,000 (Direct) |
View |
| 2017-06-15 Option Award |
2017-06-16 7:45 pm |
N/A 2027-06-14 |
Aclaris Therapeutics Inc. | ACRS | Powell Andrew Kenneth William Director |
8,000 | $24.58 | 8,000 (Direct) |
View |
| 2017-06-15 Option Award |
2017-06-16 7:44 pm |
N/A 2027-06-14 |
Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director |
8,000 | $24.58 | 8,000 (Direct) |
View |
| 2017-06-15 Option Award |
2017-06-16 7:43 pm |
N/A 2027-06-14 |
Aclaris Therapeutics Inc. | ACRS | Mehra Anand Director |
8,000 | $24.58 | 8,000 (Direct) |
View |
| 2017-03-17 Exercise |
2017-03-21 8:43 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director |
6,702 | $0.41 | 7,605 (Direct) |
View |
| 2017-03-17 Exercise |
2017-03-21 8:43 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director |
592 | $1.52 | 7,605 (Direct) |
View |
| 2017-03-17 Exercise |
2017-03-21 8:43 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director |
311 | $0.72 | 7,605 (Direct) |
View |
| 2017-03-17 Exercise |
2017-03-21 8:43 pm |
N/A 2024-01-28 |
Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director |
6,702 | $0.41 | 7,605 (Direct) |
View |
| 2017-03-17 Exercise |
2017-03-21 8:43 pm |
N/A 2024-12-07 |
Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director |
592 | $1.52 | 7,605 (Direct) |
View |
| 2017-03-17 Exercise |
2017-03-21 8:43 pm |
N/A 2024-08-12 |
Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director |
311 | $0.72 | 7,605 (Direct) |
View |
| 2017-01-25 Option Award |
2017-01-26 5:37 pm |
N/A 2027-01-24 |
Aclaris Therapeutics Inc. | ACRS | Powell Andrew Kenneth William Director |
16,000 | $27.3 | 16,000 (Direct) |
View |
| 2016-12-19 Other |
2016-12-21 10:58 am |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | FMR LLC Other |
639,627 | $0 | 1,931,727 (Indirect) |
View |
| 2016-12-18 Exercise |
2016-12-20 6:51 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Powala Christopher Chief Operating Officer |
1,625 | $0 | 132,059 (Direct) |
View |
| 2016-12-18 Tax Withholding |
2016-12-20 6:51 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Powala Christopher Chief Operating Officer |
494 | $31.25 | 132,059 (Direct) |
View |
| 2016-12-18 Exercise |
2016-12-20 6:51 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Powala Christopher Chief Operating Officer |
1,625 | $0 | 132,059 (Direct) |
View |
| 2016-12-18 Exercise |
2016-12-20 6:51 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer |
1,250 | $0 | 143,952 (Direct) |
View |
| 2016-12-18 Tax Withholding |
2016-12-20 6:51 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer |
380 | $31.25 | 143,952 (Direct) |
View |
| 2016-12-18 Exercise |
2016-12-20 6:51 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer |
1,250 | $0 | 143,952 (Direct) |
View |
| 2016-12-18 Exercise |
2016-12-20 6:50 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer |
1,075 | $0 | 77,032 (Direct) |
View |
| 2016-12-18 Tax Withholding |
2016-12-20 6:50 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer |
327 | $31.25 | 77,032 (Direct) |
View |
| 2016-12-18 Exercise |
2016-12-20 6:50 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer |
1,075 | $0 | 77,032 (Direct) |
View |
| 2016-12-18 Exercise |
2016-12-20 6:49 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Walker Neal President and CEO Director |
2,925 | $0 | 874,908 (Direct) |
View |
| 2016-12-18 Tax Withholding |
2016-12-20 6:49 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Walker Neal President and CEO Director |
889 | $31.25 | 874,908 (Direct) |
View |
| 2016-12-18 Exercise |
2016-12-20 6:49 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Walker Neal President and CEO Director |
2,925 | $0 | 874,908 (Direct) |
View |
| 2016-12-18 Exercise |
2016-12-20 6:49 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Shanler Stuart Chief Scientific Officer |
1,450 | $0 | 262,319 (Direct) |
View |
| 2016-12-18 Tax Withholding |
2016-12-20 6:49 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Shanler Stuart Chief Scientific Officer |
441 | $31.25 | 262,319 (Direct) |
View |
| 2016-12-18 Exercise |
2016-12-20 6:49 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Shanler Stuart Chief Scientific Officer |
1,450 | $0 | 262,319 (Direct) |
View |
| 2016-12-15 Option Award |
2016-12-19 5:23 pm |
N/A 2026-12-14 |
Aclaris Therapeutics Inc. | ACRS | Shanler Stuart Chief Scientific Officer |
62,400 | $28.92 | 62,400 (Direct) |
View |
| 2016-12-15 Option Award |
2016-12-19 5:23 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Shanler Stuart Chief Scientific Officer |
10,400 | $0 | 62,400 (Direct) |
View |
| 2016-12-15 Option Award |
2016-12-19 5:22 pm |
N/A 2026-12-14 |
Aclaris Therapeutics Inc. | ACRS | Powala Christopher Chief Operating Officer |
62,400 | $28.92 | 62,400 (Direct) |
View |
| 2016-12-15 Option Award |
2016-12-19 5:22 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Powala Christopher Chief Operating Officer |
10,400 | $0 | 62,400 (Direct) |
View |
| 2016-12-15 Option Award |
2016-12-19 5:22 pm |
N/A 2026-12-14 |
Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer |
62,400 | $28.92 | 62,400 (Direct) |
View |
| 2016-12-15 Option Award |
2016-12-19 5:22 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer |
10,400 | $0 | 62,400 (Direct) |
View |
| 2016-12-15 Option Award |
2016-12-19 5:21 pm |
N/A 2026-12-14 |
Aclaris Therapeutics Inc. | ACRS | Walker Neal President and CEO Director |
145,600 | $28.92 | 145,600 (Direct) |
View |
| 2016-12-15 Option Award |
2016-12-19 5:21 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Walker Neal President and CEO Director |
24,266 | $0 | 145,600 (Direct) |
View |
| 2016-12-15 Option Award |
2016-12-19 5:21 pm |
N/A 2026-12-14 |
Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer |
83,200 | $28.92 | 83,200 (Direct) |
View |
| 2016-12-15 Option Award |
2016-12-19 5:21 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer |
13,866 | $0 | 83,200 (Direct) |
View |
| 2016-10-26 Exercise |
2016-10-28 4:10 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer |
3,912 | $1.52 | 79,869 (Direct) |
View |
| 2016-10-26 Exercise |
2016-10-28 4:10 pm |
N/A 2024-12-07 |
Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer |
3,912 | $1.52 | 79,869 (Direct) |
View |
| 2016-10-19 Other |
2016-10-20 4:20 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | FMR LLC Other 10% Owner |
84,223 | $0 | 2,575,104 (Indirect) |
View |
| 2016-09-26 Exercise |
2016-09-28 6:10 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer |
1,841 | $0.72 | 77,798 (Direct) |
View |
| 2016-09-26 Exercise |
2016-09-28 6:10 pm |
N/A 2024-08-12 |
Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer |
1,841 | $0.72 | 77,798 (Direct) |
View |
| 2016-09-15 Other |
2016-09-19 7:08 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Tullman Stephen A. Director |
521,739 | $0 | 394,014 (Indirect) |
View |
| 2016-09-15 Other |
2016-09-19 7:08 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Tullman Stephen A. Director |
116,999 | $0 | 394,014 (Direct) |
View |
| 2016-09-15 Other |
2016-09-19 7:08 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Tullman Stephen A. Director |
144,153 | $0 | 394,014 (Indirect) |
View |
| 2016-09-15 Other |
2016-09-19 7:08 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Tullman Stephen A. Director |
50,002 | $0 | 394,014 (Indirect) |
View |
| 2016-09-15 Other |
2016-09-19 7:08 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Tullman Stephen A. Director |
4,790 | $0 | 394,014 (Direct) |
View |
| 2016-09-15 Other |
2016-09-19 7:07 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer |
50,878 | $0 | 75,957 (Direct) |
View |
| 2016-09-15 Other |
2016-09-19 7:07 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer |
4,790 | $0 | 75,957 (Direct) |
View |
| 2016-09-15 Other |
2016-09-19 7:07 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer |
4,790 | $0 | 142,702 (Direct) |
View |
| 2016-09-15 Other |
2016-09-19 7:06 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Walker Neal President and CEO Director |
81,686 | $0 | 871,983 (Direct) |
View |
| 2016-09-15 Other |
2016-09-19 7:06 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Walker Neal President and CEO Director |
4,790 | $0 | 871,983 (Direct) |
View |
| 2016-09-01 Option Award |
2016-09-02 6:13 pm |
N/A 2026-08-31 |
Aclaris Therapeutics Inc. | ACRS | Humphries William D. Director |
10,000 | $20.68 | 10,000 (Direct) |
View |
| 2016-08-30 Other |
2016-08-31 11:09 am |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | FMR LLC Other 10% Owner |
130,571 | $0 | 2,659,327 (Indirect) |
View |
| 2016-06-29 Option Award |
2016-07-01 4:17 pm |
N/A 2026-06-28 |
Aclaris Therapeutics Inc. | ACRS | Bierly Rick Director |
6,632 | $18.32 | 6,632 (Direct) |
View |
| 2016-06-29 Option Award |
2016-07-01 4:17 pm |
N/A 2026-06-28 |
Aclaris Therapeutics Inc. | ACRS | CHA ALBERT Director |
6,632 | $18.32 | 6,632 (Direct) |
View |
| 2016-06-29 Option Award |
2016-07-01 4:16 pm |
N/A 2026-06-28 |
Aclaris Therapeutics Inc. | ACRS | Mehra Anand Director 10% Owner |
6,632 | $18.32 | 6,632 (Direct) |
View |
| 2016-06-29 Option Award |
2016-07-01 4:15 pm |
N/A 2026-06-28 |
Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director |
6,632 | $18.32 | 6,632 (Direct) |
View |
|
© 2005-2018 SecForm4.Com All rights reserved. Archives: 2018 2017 2016 2015 2014 2013 ... Sun, 20 May 2018 04:55:53 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |